Sanara MedTech Inc.
HealthcareNASDAQ:SMTI · NASDAQ Capital Market
-$0.69 today
Vol 0.05M · Avg 0.05M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Earnings Waterfall
Revenue to Net Income
Key Ratios
Analysis
$107.5M of revenue converted into -$33.6M of net income for the selected period. Gross margin is 91.2% and net margin is -31.9%, showing how much revenue survives after costs and taxes. EPS is $-3.90, tying the income statement back to per-share earnings.
Income Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $103.1M +19.0% | $86.7M +33.4% | $65.0M +41.8% | $45.8M +89.9% | $24.1M | $809.6M | $921.6M | $731.2M |
| Cost of Revenue | $10.2M +25.1% | $8.1M +3.7% | $7.9M +23.5% | $6.4M +175.2% | $2.3M | $725.6M | $804.0M | $882.4M |
| Gross Profit | $92.9M +18.3% | $78.5M +37.4% | $57.1M +44.7% | $39.5M +80.8% | $21.8M | $8.9B | $7.6B | $6.2B |
| Gross Margin | 90.1% -0.5pp | 90.6% +2.7pp | 87.9% +1.8pp | 86.1% -4.3pp | 90.4% | 9.8% | 28.9% | 38.3% |
| Research & Development | $5.1M -11.1% | $5.7M +38.0% | $4.1M +22.7% | $3.4M +502.7% | $558.7K | $983.2M | $1.3B | $490.4M |
| Selling, General & Admin | $78.7M +2.8% | $76.6M +34.3% | $57.0M +24.0% | $46.0M +63.9% | $28.1M | $620.6M | $923.0M | -$1.5B |
| Operating Expenses | $83.8M -1.7% | $85.2M +38.9% | $61.4M +18.0% | $52.0M +78.0% | $29.2M | $5.3B | $7.0B | $8.7B |
| Depreciation & Amortization | $2.7M -45.9% | $4.9M +34.0% | $3.7M +55.0% | $2.4M +207.2% | $771.9K | $374.2M | $1.2B | $631.8M |
| EBITDA | $9.0M +585.3% | -$1.9M -543.5% | -$289.1K +97.5% | -$11.6M -60.2% | -$7.2M | -$15.2B | $6.8B | $9.3B |
| EBITDA Margin | 8.8% +10.9pp | -2.1% -1.7pp | -0.4% +24.8pp | -25.2% +4.7pp | -29.9% | 5.6% | 46.3% | 42.0% |
| Operating Income | $9.1M +236.2% | -$6.7M -59.3% | -$4.2M +66.3% | -$12.5M -69.7% | -$7.4M | $12.3B | $14.0B | -$15.7B |
| Operating Margin | 8.9% +16.6pp | -7.7% -1.3pp | -6.5% +20.8pp | -27.3% +3.2pp | -30.6% | 16.6% | 24.1% | 22.0% |
| Interest Income | $3.7K -83.3% | $22.0K | $0 -100.0% | $284.7K | $0 | -$1.5B | -$1.6B | $405.0M |
| Interest Expense | $6.8M +116.1% | $3.1M +557.5% | $475.8K +67.1% | $284.7K +39948.7% | $711 | $1.1B | $1.0B | $1.2B |
| Other Income / Expenses | -$9.5M -198.4% | -$3.2M -1322.2% | -$224.7K +84.2% | -$1.4M -129.9% | -$617.6K | -$1.5B | $1.4B | $1.2B |
| Income Before Tax | -$393.1K +96.0% | -$9.9M -123.2% | -$4.4M +68.1% | -$13.9M -74.3% | -$8.0M | $3.3B | $4.9B | $3.6B |
| Pre-Tax Margin | -0.4% +11.1pp | -11.4% -4.6pp | -6.8% +23.6pp | -30.4% +2.7pp | -33.1% | 20.8% | 18.7% | 26.2% |
| Income Tax Expense | $0 | $0 | $0 +100.0% | -$5.8M | $0 | $1.3B | -$1.6B | $745.2M |
| Net Income | -$37.6M -288.7% | -$9.7M -124.6% | -$4.3M +45.8% | -$7.9M -0.2% | -$7.9M | $4.9B | $4.8B | $4.7B |
| Net Margin | -36.4% -25.3pp | -11.2% -4.5pp | -6.6% +10.7pp | -17.3% +15.5pp | -32.8% | 12.4% | 17.5% | 22.5% |
| EPS (Basic) | -$4 -282.5% | -$1 -119.2% | -$1 +48.0% | -$1 +7.4% | -$1 | $400.8M | $703.2M | $1.3B |
| EPS (Diluted) | -$4 -282.5% | -$1 -119.2% | -$1 +48.0% | -$1 +7.4% | -$1 | $766.2M | $609.4M | $452.6M |
| Weighted Avg Shares | $8.6M +1.6% | $8.5M +2.5% | $8.3M +4.7% | $7.9M +7.7% | $7.3M | $757.8M | $925.8M | $1.1B |
| Weighted Avg Shares (Diluted) | $8.6M +1.6% | $8.5M +2.5% | $8.3M +4.7% | $7.9M +7.7% | $7.3M | $1.2B | $924.4M | $678.0M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Viemed Healthcare, Inc.
NASDAQ:VMD
$400.62M
TruBridge, Inc.
NASDAQ:TBRG
$391.78M
NeoGenomics, Inc.
NASDAQ:NEO
$290.37M
Sight Sciences, Inc.
NASDAQ:SGHT
$279.12M
Entrada Therapeutics, Inc.
NASDAQ:TRDA
$250.78M
LifeMD, Inc.
NASDAQ:LFMD
$227.30M
Owens & Minor, Inc.
OMI
$207.07M
High Tide Inc.
NASDAQ:HITI
$203.04M
Stereotaxis, Inc.
AMEX:STXS
$179.84M
Exagen Inc.
NASDAQ:XGN
$112.83M
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does SMTI generate?
Sanara MedTech Inc. (SMTI) reported $103.12M of revenue in fiscal 2025.
Is SMTI profitable?
Sanara MedTech Inc. (SMTI) reported -$37,562,606.00 of net income, with a net margin of -36.4%.
Explore More
Continue the stock analysis
Jump to another research area for this company.